0.80 +0.00 (0.00%)
NGSX
| Trade NGSX now with |
|
Stock Details
Last Trade:0.80 Change:+0.00 (0.00%) Prev Close:0.80 Open: 5.73 Days Range:0.80 – 0.80 52 Week Range: 0.66 - 5.80 Volume:17722 P/E: N/AEPS:-2.69
View AllRecent Alerts 02/09/12
Recent Alert on 02/09/12 at 6:46pm
After-Hours Movers 02/09: (SWIR) (LNKD) (UEPS) Higher; (NGSX) (XIDE) (TRLG) (NUAN) Lower
After-Hours Movers 02/09: (SWIR) (LNKD) (UEPS) Higher; (NGSX) (XIDE) (TRLG) (NUAN) Lower
NeurogesX (Nasdaq: NGSX) 25% LOWER; today announced that the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to the U.S. FDA did not recommend FDA approval of a new indication for Qutenza® (Capsaicin) 8% patch for the... Read More
Recent Alert on 02/09/12 at 5:47pm
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
Recent Alert on 02/09/12 at 5:47pm
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
View AllRecent Press Releases
Press Release on 02/09/12 at 5:30pm
NeurogesX Provides Update on Qutenza(R) (Capsaicin) 8% Patch for New Indication to Treat HIV-PN Following FDA Advisory Committee Review
NeurogesX Provides Update on Qutenza(R) (Capsaicin) 8% Patch for New Indication to Treat HIV-PN Following FDA Advisory Committee Review